Sign in

Soon, medical colleges may need drug-resistant TB centres to get recognised

The government has proposed making drug-resistant tuberculosis centres mandatory for a medical college to get recognition. The move is aimed at ensuring that patients have access to a facility nearby, correct diagnosis is made and appropriate treatment is started in time.

Updated on: Apr 20, 2018, 07:19:27 IST
Hindustan Times, New Delhi | By
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

Opening centres to treat drug-resistant (DR) tuberculosis could soon be made mandatory for medical colleges applying for recognition. The Union health ministry has written to the Medical Council of India (MCI), proposing to make it a prerequisite for the recognition of a medical college in the country.

Schoolchildren hold placards as they take part in a tuberculosis awareness campaign at a railway station in Chennai. An estimated 1,47,000 people suffer from multi-drug resistant (MDR) TB in India. (AFP File Photo)
Schoolchildren hold placards as they take part in a tuberculosis awareness campaign at a railway station in Chennai. An estimated 1,47,000 people suffer from multi-drug resistant (MDR) TB in India. (AFP File Photo)

An estimated 1,47,000 people suffer from multi-drug resistant (MDR) TB in India, and there are many who are infected but not diagnosed or on treatment and run the risk of infecting others.

The move is aimed at ensuring that patients suffering from drug-resistant TB have access to a facility nearby and correct diagnosis is made and appropriate treatment is started in time, which is a part of the government’s ‘End TB by 2025’ strategy.

In a letter to the MCI last month, health secretary Preeti Sudan requested the MCI to “incorporate the obligatory requirement of establishing DR-TB centre for treatment initiation of DR-TB patients as per revised national TB control programme guidelines at each medical college for recognition of medical college”.

India, with 27.9 lakh tuberculosis cases, 4.23 lakh disease-related deaths, and an average of 211 new infections diagnosed per 100,000 people, has the highest number of tuberculosis patients across the globe. There are currently 147 MDR-TB treatment centres, and with the addition of this new clause the ministry hopes to create enough centres for treatment to be readily accessible as MDR TB requires a different and more extensive treatment regimen.

As part of its End TB strategy, the health ministry is formulating several innovative interventions, with special focus on drug-resistant TB. These include making use of its 4.5 lakh Directly Observed Treatment, Short-Course (DOTS) providers for advocacy and active case finding.

The ministry will also start mapping slums to identify TB cases and put positive ones on treatment.

States have also been asked to identify two blocks in each district to make it TB-free within a year, as a part of its disease elimination strategy. The Centre will also rank districts on disease prevalence to get an exact idea of disease distribution.

A concrete project implementation plan should be ready by the end of April or mid-May.

“Our target is to eliminate TB by 2025, so we have to act now. The system is already in place, but we need to make it more structured to be able to achieve the target,” said Sanjeeva Kumar, additional secretary (health).

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More